Erwin Grussie

Erwin Grussie practices at Cedars-Sinai Medical Care Foundation in Beverly Hills, California.

Erwin Grussie's NPI, 1679917561, was assigned on April 22, 2013. Erwin Grussie graduated from Charité - Universitätsmedizin Berlin in 2008. Erwin Grussie holds California license A138355.

Erwin Grussie's primary practice is Cedars-Sinai Medical Care Foundation, at 8501 Wilshire Blvd, Beverly Hills, CA 90211 in Los Angeles County. The practice phone is (310) 385-3200.

Erwin Grussie's primary practice is Cedars-Sinai Medical Care Foundation in Beverly Hills, California. Erwin Grussie is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Erwin Grussie to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Erwin Grussie practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Erwin Grussie's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Erwin Grussie is board certified in hematology by the American Board of Internal Medicine. Erwin Grussie is licensed in California.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, lung cancer, lymphoma and multiple myeloma among the conditions Erwin Grussie treats.

CMS data shows 17,001 Medicare services from Erwin Grussie across 18 procedure codes in 2024, for 515 Medicare patients. Medicare paid $498,708 for them.

CMS counts 515 Medicare patients who saw Erwin Grussie in 2024. The largest group is 75 to 84, with 191 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Erwin Grussie's median patient age at 73, with 59% women.

In 2024, Erwin Grussie wrote 1,587 Medicare Part D claims for 220 patients. 78% of them were for generic drugs. CMS names the drug for 1,306 of them, across 39 drugs with 11 or more claims each, at $2,128,884 in total drug cost. In 2023, CMS named 981 claims across 33 drugs.

Erwin Grussie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Erwin Grussie as offering telehealth.

Dmand AI links 1 paper to Erwin Grussie in 2019. Erwin Grussie's most frequent co-authors are Andrew M. Brunner, MD, Andrew A. Lane, MD, PhD and Raajit Rampal, MD.

Dmand AI links Erwin Grussie to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 63 general payments to Erwin Grussie from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Amgen Inc. paid the most, $789. It also lists 1 research payment totaling $8,324 in 2022.

Erwin Grussie graduated from Charité - Universitätsmedizin Berlin in 2008.

Erwin Grussie is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.